Occult tumor cell contamination in patients with stage II/III breast cancer receiving sequential high-dose chemotherapy
✍ Scribed by Viret, F; Chabannon, C; Sainty, D; Genre, D; Gonçalves, A; Arnoulet, C; Gravis, G; Bertucci, F; Houvenaeghel, G; Jacquemier, J
- Book ID
- 110013946
- Publisher
- Nature Publishing Group
- Year
- 2003
- Tongue
- English
- Weight
- 138 KB
- Volume
- 32
- Category
- Article
- ISSN
- 0007-1188
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The present study aimed to investigate the clinical relevance of disseminated tumor cells (DTC) in breast cancer patients before and after high‐dose adjuvant chemotherapy with or without progenitor stem‐cell support. One hundred and eighteen high‐risk stage II breast cancer patients ent
## Abstract ## BACKGROUND The objective of this study was to compare the quality of life (QOL) after treatment among patients who had breast carcinoma with multiple positive lymph nodes. The patients were randomized to receive either high‐dose chemotherapy with autologous stem cell support (HDC) o